baber/WOPTO huggingface dataset:
Patent MX-2009003761-A (MX)
Title: Bicyclic and tricyclic derivatives as thrombin receptor antagonists.
Inventor: XIA YAN
IPC: C07D401/06
Filed: 2007-10-02
Abstract: Heterocyclic-substituted tricyclics of the formula (I) or a pharmaceutically acceptable salt or solvate of said compound, isomer or racemic mixture wherein represents an optional double bond, the dotted line is optionally a bond or no bond, resulting in a double bond or a single bond, as permitted by the valency requirement and wherein E, A, G M, Het, B, X, R<sup>3</sup>, R<sup>10</sup>, R<sup>11</sup>, R<sup>32</sup> and R<sup>33</sup> are herein defined and the remaining substituents are as defined in the specification, are disclosed, as well as pharmaceutical compositions containing them and a method of treating diseases associated with thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failure, and cancer by administering said compounds. Combination therapy with other cardiovascular agents is also claimed.
Patent MX-2009004035-A (MX)
Title: Treated expanded polystyrene foam.
Inventor: UPADHYAY NAVNIT BHLESHWAR
IPC: C08J9/224
Filed: 2007-10-12
Abstract: Expanded polystyrene coated with at least one organic pesticide, methods for making expanded polystyrene coated with at least one organic pesticide, and molded articles made from expanded polystyrene coated with at least one organic pesticide is provided herein.
Patent MX-2009005727-A (MX)
Title: Amphiphilic entity nanoparticles.
Inventor: KOTYLA TIMOTHY
IPC: A61K8/99
Filed: 2007-11-30
Abstract: The present invention provides nanoparticle compositions comprising AE nanoparticles. The present invention provides AE nanoparticles comprising one or more amphiphilic entities and pharmaceutical compositions comprising AE nanoparticles. The present invention provides methods of manufacturing AE nanoparticles. The present invention provides methods of delivering a biologically active agent to a subject by administering AE nanoparticles containing a biologically active agent to a subject.
Patent MX-2009006009-A (MX)
Title: 4-hydr0xy-2-0x0-2, 3 -dihydro- 1, 3-benzothiazol- 7yl compounds for modulation of b2-adrenoreceptor activity.
Inventor: CONNOLLY STEPHEN
IPC: C07D417/12
Filed: 2007-12-19
Abstract: The present invention provides compounds of formula (I) (A chemical formula should be inserted here - please see paper copy enclosed herewith) wherein Ra, Rb, R1, R2, R3, R4, R5, R6 and R29 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
Patent MX-2009009169-A (MX)
Title: Tissue products containing non-fibrous polymeric surface structures and a topically-applied softening composition.
Inventor: GOULET MIKE THOMAS
IPC: C08L83/04
Filed: 2008-01-24
Abstract: Soft tissue products with a good rate of absorbency, such as facial and bath tissue, are provided by forming a tissue sheet with a non-fibrous polymeric surface structure and thereafter topically applying a softening composition comprising a polysiloxane, a fatty alkyl derivative and glycerin. The non-fibrous polymeric surface structure is created by applying an additive composition to the surface of a tissue sheet prior to or after drying. The additive composition can be an aqueous dispersion containing an alpha-olefin polymer, an ethylene-carboxylic acid copolymer, or mixtures thereof. The alpha-olefin polymer may comprise an interpolymer of ethylene and octene, while the ethylene-carboxylic acid copolymer may comprise ethylene-acrylic acid copolymer.
Patent MX-2009010205-A (MX)
Title: P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease.
Inventor: SHIH NENG-YANG
IPC: C07D401/12
Filed: 2008-03-20
Abstract: The present invention discloses novel compounds, which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
Patent MX-2010001333-A (MX)
Title: Stable composition of hibiscus sabdariffa l. calyces for the manufacture of drugs, food supplements, functional food and sweeteners.
Inventor: LEGORRETA XAVIER LOZOYA
IPC: A61K8/97
Filed: 2010-02-03
Abstract: The present invention comprises stable compositions of Hibiscus calyces, which includes polymeric matrixes, as well as simple and efficient methods for obtaining the same. The described compositions contain a high concentration (more than 95% by weight) of the original anthocyanins detected in the calyces of the plant, which allows the same to be used as sweetener compositions and as raw material for obtaining drugs.
Patent MX-2010002086-A (MX)
Title: Moveable sensor array and method of detecting location of calibration fault.
Inventor: PHILLIPS SCOTT J
IPC: G01B11/00
Filed: 2010-02-23
Abstract: A printing device comprises a print head, imaging member, and a moveable sensor array. The print head is configured to deliver marking material to the imaging member as it moves in a process direction. The linear sensor array comprises a plurality of photo sensors configured to scan the imaging member. The photo detectors of the linear sensor array define a sensor axis that is substantially perpendicular to the process direction. The linear sensor array is configured to move along the sensor axis between a first position where the sensor array scans one portion of the imaging member and a second position where the sensor array scans another portion of the imaging member. If a fault is detected during calibration of the sensor array, the moveable sensor array may be used to determine whether the source of the fault rests with the imaging member or the sensor array.
Patent MX-2010002093-A (MX)
Title: Hydraulic fluid compositions and preparation thereof.
Inventor: ROSENBAUM JOHN M
IPC: C10M145/14
Filed: 2008-08-25
Abstract: A hydraulic fluid composition having excellent oxidation stability prepared from an isomerized base oil is provided. The composition comprising (i) 80 to 99.999 wt. % of a lubricating base oil having consecutive numbers of carbon atoms, less than 10 wt% naphthenic carbon by n-d-M; and (ii) 0.001 - 20 wt % of at least an additive package. The hydraulic fluid composition meets the performance specifications of at least one of the JCMAS HK and JCMAS HKB standard specifications issued by the Fuels and Lubricants Technical Committee of Japan Construction Mechanization Association (JCMA).
Patent MX-2010002711-A (MX)
Title: Device and method for treating a medical fluid and medical cassette.
Inventor: WEBER TOBIAS
IPC: A61M1/28
Filed: 2008-05-16
Abstract: The invention relates to a device for treating a medical fluid, said device comprising a treatment machine with a coupling surface, to which a cassette consisting of a hard part with fluid-conducting channels that are covered by a flexible film can be coupled. The invention also relates to a corresponding medical cassette. According to the invention, to guarantee that the film of the cassette can be coupled to the treatment machine without the inclusion of air, air can be sucked off along the plane lying between the flexible film and the coupling surface during the coupling process and/or when the cassette is coupled to the machine. The invention also relates to a method for coupling the cassette and to a method for checking the leak-tightness of the cassette by means of the regulation of the air removal by suction.
Patent MX-2010004682-A (MX)
Title: A method of hormone suppression in humans.
Inventor: SCHIPPER JACQUES
IPC: A61K31/198
Filed: 2008-11-04
Abstract: The present invention relates to a glycine transporter-1 inhibitor having the formula (I) wherein X is 1-3 substituents selected from H, halogen, methyl, methoxy, trifluoromethyl and trifluoromethoxy and Y is 1-3 substituents selected from H, methyl and halogen or a pharmaceutically acceptable salt thereof for use in a treatment in humans to suppress the level of one or more hormone selected from luteinizing hormone, follicle-stimulating hormone, estradiol and testosterone. The present invention further relates to such a glycine transporter-1 inhibitor as part of a contraceptive regimen or as a treatment for hypersexuality.
Patent MX-2010004719-A (MX)
Title: Mould material mixture having improved flowability.
Inventor: KOCH DIETHER
IPC: B22C1/18
Filed: 2008-10-30
Abstract: The invention relates to a mould material mixture for producing casting moulds for metal processing, a process for producing casting moulds, casting moulds which can be obtained by the process and their use. The production of the casting moulds is carried out using a refractory base moulding material and a binder based on water glass. A proportion of a particulate metal oxide selected from the group consisting of silicon dioxide, aluminium oxide, titanium oxide and zinc oxide is added to the binder, with particular preference being given to using synthetic amorphous silicon dioxide. The mould material mixture contains a surface-active material as further significant constituent. The addition of the surface-active material enables the flowability of the mould material mixture to be improved, which makes it possible to produce casting moulds having a very complicated geometry.
Patent MX-2010004800-A (MX)
Title: Dioxoanthracene sulphonate derivatives.
Inventor: CARLINO STEFANO
IPC: A61P29/00
Filed: 2008-11-14
Abstract: Compounds that may have anti-inflammatory activity have the general formula (I): Wherein R1, R2, R3 are each independently H or a C1-4 alkyl group or a C2-4 acyl group; R4 and R5 are each independently H or a group of formula -SO3R6, wherein R6 is H or a C1-4 alkyl group or a C2-4 acyl group; with the proviso that at least one of R4 and R5 is a group of formula -SO3R6, or a pharmaceutically acceptable salt thereof.
Patent MX-2010006110-A (MX)
Title: Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors.
Inventor: CAGE PETER ALAN
IPC: A61K31/45
Filed: 2008-12-10
Abstract: The present invention provides compounds of formula (I) in which n, y, X1, X2, A, B, R1, R2, R3, R4 and R5 are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them and their use as dipeptidyl peptidase I (DPPI) inhibitors.
Patent MX-2010006567-A (MX)
Title: Method patterns for intrastromal refractive surgery.
Inventor: RUIZ LUIS ANTONIO
IPC: A61F9/01
Filed: 2008-11-21
Abstract: A method for performing intrastromal ophthalmic laser surgery requires Laser Induced Optical Breakdown (LIOB) of stromal tissue without compromising Bowman's capsule (membrane). In detail, the method creates cuts in the stroma along planes radiating from the visual axis of the eye. Importantly, these cuts are all distanced from the visual axis. The actual location and number of cuts in the surgery will depend on the degree of visual aberration being corrected. Further, the method may include the additional step of creating cylindrical cuts in the stroma. The radial cuts and cylindrical cuts may be intersecting or non-intersecting depending on the visual aberration being treated.
Patent MX-2010008034-A (MX)
Title: Apparatus and method for computing control information for an echo suppression filter and apparatus and method for computing a delay value.
Inventor: FALLER CHRISTOF
IPC: H04M9/08
Filed: 2009-01-12
Abstract: An embodiment of an apparatus (200) for computing control information for a suppression filter (210) for filtering a second audio signal to suppress an echo based on a first audio signal includes a computation means (220) having a value determination means (230) for determining at least one energy-related value for a band-pass signal of at least two temporally successive data blocks of at least one signal of a group of signals. The computation means (220) further includes a mean value determination means (250) for determining at least one mean value of the at least one determined energy-related value for the band-pass signal. The computation means (220) further includes a modification means (260) for modifying the at least one energy-related value for the band-pass signal on the basis of the determined mean value for the band-pass signal. The computation means (220) ' further includes a control information computation means (270) for computing the control information for the suppression filter (210) on the basis of the at least one modified energy-related value.
Patent MX-2010010012-A (MX)
Title: Azetidine and cyclobutane derivatives as jak inhibitors.
Inventor: RODGERS JAMES D
IPC: A61P35/00
Filed: 2009-03-10
Abstract: The method includes the steps of performing in-vitro liver, intestinal and/or expressed enzyme assays with selected ethnobotanical substances, for both humans and a variety of animal species, to produce an array of resulting chemical entities, such as metabolites, for the human and the animals. Comparisons are then made between the chemical entities from the human in-vitro studies and the animal in-vitro studies to determine the closest match. The animal with the closest match is then used for an in-vivo study. If a match is present between the animal in-vivo results and the human in-vitro results, the matched chemical entity is isolated or synthesized and then further tested to determine the suitability of the matched chemical entity as a treatment drug.
Patent MX-2010011942-A (MX)
Title: Automatic transport loading system and method.
Inventor: CHILSON GERALD EDWARD
IPC: G01C22/00
Filed: 2009-04-28
Abstract: A method and system for automatically loading and unloading a transport is disclosed. A guidance system follows a travel path to a position near the transport and then a sensor profiles a transport so that a transport path is determined for an AGV to follow into the transport to place a load and for exiting the transport upon placement of the load.
Patent MX-2010012101-A (MX)
Title: Method of treating cancer using a cmet and axl inhibitor and an erbb inhibitor.
Inventor: SHI HONG
IPC: C07D401/00
Filed: 2009-05-05
Abstract: The present invention relates to a method of treating cancer in a patient comprising administering to the patient therapeutically effective amounts of: a) a compound of formula A: or a pharmaceutically acceptable salt thereof, wherein R1 - R4, p, and q are as defined; and (b) an erbB inhibitor that inhibits erbB-1 or erbB-2 or erbB-3 receptor or a combination thereof. The method of the present invention addresses a need in the art with the discovery of a combination therapy that shows evidence of being a more effective therapy than previously disclosed therapies.
Patent MX-2010014088-A (MX)
Title: Footer cleat for insulating concrete form.
Inventor: RUBB JUSTIN
IPC: E04B2/86
Filed: 2009-06-11
Abstract: Methods of constructing concrete walls that include placing a plurality of cleats along a wall perimeter, securing the cleats to a surface under the wall perimeter, placing a plurality of insulating concrete forms along the perimeter, and placing concrete into the insulating concrete forms to form the insulating concrete wall. The cleats include a base plate, a first vertical flange extending approximately perpendicular from the base plate, and a second vertical flange extending approximately parallel to the first vertical flange. The space defined by the first vertical flange, second vertical flange and the base plate, is adapted to receive a bottom portion of a form component or a bottom portion of a form. The insulating concrete forms are placed along the perimeter such that a bottom portion of the form components or a bottom portion of the form are press fit into the defined space.
Patent MX-2011000211-A (MX)
Title: Oxazolopyrimidines as edg-1 receptor agonists.
Inventor: SCHAEFER MATTHIAS
IPC: A61P7/02
Filed: 2009-07-02
Abstract: The present invention relates to oxazolopyrimidine compounds of the formula I in which A, R1, R2 and R3 are defined as indicated in the claims. The compounds of the formula I modulate the activity of the Edg-1 receptor and in particular are agonists of this receptor, and are useful for the treatment of diseases such as atherosclerosis, heart failure or peripheral arterial occlusive disease, for example. The invention furthermore relates to processes for the preparation of compounds of the formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.
Patent MX-2011003482-A (MX)
Title: Undulated progressive tire mold element.
Inventor: CHRISTENBURY DAMON L
IPC: B29D30/06
Filed: 2008-10-03
Abstract: Particular embodiments of the present invention include an undulating sipe mold member (10) and a corresponding sipe formed within a tire tread. In a particular embodiment, the present invention includes an undulating sipe mold member (10) for use in a mold, the mold member comprising: an upper mold member (12) extending downwardly from a top end to a bottom end; and, a first lower projection member (14) and a second lower projection member(16), each lower member extending downward from the initial extension, the sipe mold member (10) having a sweep axis along which the sipe mold member undulates in a desired path.
Patent MX-2011004276-A (MX)
Title: Transition metal complexes of bis[thiohydrazide amide] compounds.
Inventor: NAGAI MASAZUMI
IPC: C07C327/00
Filed: 2009-10-21
Abstract: The present invention is directed to a compound comprising a bis[thiohydrazide amide] or a deprotonated form thereof, complexed to a transition metal cation, wherein the bis[thiohydrazide amide] is represented by Structural Formula (I):, or a prodrug, isomer, ester, salt, hydrate, solvate, polymorph or a deprotonated form thereof. In one embodiment, the compound is represented by Structural Formula (II):, or a prodrug, isomer, ester, salt, hydrate, solvate or polymorph thereof. The present invention also provides a pharmaceutical composition comprising the compound of the invention and method of use thereof.
Patent MX-2011004981-A (MX)
Title: Container base structure responsive to vacuum related forces.
Inventor: SILVERS KERRY W
IPC: B65D1/02
Filed: 2009-10-28
Abstract: A plastic container having a base portion adapted for vacuum pressure absorption. The base portion including a contact ring that supports the container, an upstanding wall, and a central portion. The upstanding wall being adjacent to and generally circumscribing the contact ring. The central portion defined in at least part by a pushup and an inversion ring that generally circumscribes the pushup. The pushup and the inversion ring being moveable to accommodate vacuum related forces generated within the container.
Patent MX-2011006153-A (MX)
Title: Method and apparatus for deghosting seismic data.
Inventor: SOUBARAS ROBERT
IPC: G01V1/28
Filed: 2011-06-09
Abstract: Apparatus, computer instructions and method for deghosting seismic data related to a subsurface of a body of water. The method includes inputting data recorded by detectors that are towed by a vessel, the data being associated with waves travelling from the subsurface to the detectors; applying a migration procedure to the data to determine a first image of the subsurface; applying a mirror migration procedure to the data to determine a second image of the subsurface; joint deconvoluting the first image and the second image for deghosting a reflectivity of the subsurface; and generating a final image of the subsurface based on the deghosted reflectivity of the joint deconvoluting step.
Patent MX-2011006329-A (MX)
Title: Process for reducing the content of fat in fried snacks.
Inventor: HENAINE GREGORIO WILEBALDO PEREZ-PALACIOS Y
IPC: A23L1/00
Filed: 2011-06-14
Abstract: The present invention refers to an independent process for extruding and expanding two types of pellets, which are subsequently mixed for reducing and adjusting the amount of grease or fat in a fried pellet snack. The process is based on mixing the obtained snack upon expanding the pellet by means of two independent processes. On one hand, the expansion of the snack is performed by a frying process and on the other hand the snack being expanded by a hot air process. After the independent expansion is performed, the snacks being mixed together just at the outlet of the frying process so that the snack expanded by air is impregnated with the oil of the fried snack. The difference in expansion size is compensated by using a hot-air expanded pellet bigger and more humid than that used in the frying process so as to obtain a final product with a uniform size. In such a manner, an appearance, texture and flavour similar to the frying product is obtained, a condiment being added to homogeniz e the flavour in the snacks obtained by both processes: hot-air and fry expansion.
Patent MX-2011007009-A (MX)
Title: Process for producing oxygen enriched water.
Inventor: VILLALOBOS HUMBERTO DE JESUS VEGA
IPC: C02F1/00
Filed: 2011-06-29
Abstract: The present invention relates to a process for producing oxygen enriched water. The process consists in extracting water from deep wells and subjecting the same to chlorination and then to filtration, softening and reverse osmosis so as to be mixed together with hydrogen peroxide at 3%. After water has been mixed together with hydrogen peroxide, this is passed through UV light and ozone so that bottles can be filled with this water.
Patent MX-2011010241-A (MX)
Title: Holding device for a winding material suction gun.
Inventor: HEHENBERG REINHOLD
IPC: B65H54/88
Filed: 2011-09-29
Abstract: The holding device (11) has a receptacle (19) for the winding material-suction gun, a fastening element (41) for fastening the holding device at a winding machine, and a winding material output slot (16). A guide element (12) has an inlet region for the winding material. An independent claim is also included for a method for transferring winding material..
Patent MX-2011010454-A (MX)
Title: Improvement in promotion of healthy catch-up growth.
Inventor: MACE CATHERINE
IPC: A61K38/17
Filed: 2010-03-26
Abstract: The use of a protein source comprising bovine casein proteins for the preparation of a nutritional composition for administration to an infant, young child or adult during or after a period of catch-up growth or weight recovery, following a period of growth restriction or weight lost, so as improve growth at early age and/or to reduce the risk of development of insulin resistance and/or Type 2 diabetes later in the life of the infant, young child or adult.
Patent MX-2011010760-A (MX)
Title: Core for a product in sheet form wound around this core, and roll formed with such a core.
Inventor: HOEFT BENOIT
IPC: B65H75/10
Filed: 2011-02-01
Abstract: According to the invention, the core (5) has a cylindrical wall (8) which can be torn axially and is made up of two superposed strips, these respectively being an outer strip (10) in contact with the product and an inner strip (11), these strips being wound on one another and joined together by regions of attachment for example by bonding (12). At least one of the longitudinal edges of the inner strip (11) is not attached or is weakly attached over a determined width in order, over at least part of its helical length, to form a free and accessible tab (19) facing the outer strip (10).
Patent MX-2011014055-A (MX)
Title: Method for discerning and sorting products whereby the concentration of a component of these products is determined.
Inventor: BERGHMANS PAUL
IPC: B07C5/342
Filed: 2010-06-17
Abstract: The invention concerns a method for discerning and sorting suitable products in a product flow having a certain concentration of a component versus anomalous products having this component in an anomalous concentration, whereby a beam of light strikes these products, and the absorption of this beam of light by said component in the products is detected by measuring the intensity of the light reflected by the products at least at a wavelength or in at least a wavelength band which is situated between 900 nm and 2500 run in order to generate a detection signal on the basis of said absorption, whereby a product will be identified as an anomalous product if said detection signal exceeds a threshold value.